Compare RNAZ & IVDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNAZ | IVDA |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 3.2M |
| IPO Year | 2021 | 2015 |
| Metric | RNAZ | IVDA |
|---|---|---|
| Price | $2.90 | $0.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.0K | ★ 8.4M |
| Earning Date | 04-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 51.38 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $4,468,279.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 132.98 |
| 52 Week Low | $2.87 | $0.21 |
| 52 Week High | $20.99 | $2.24 |
| Indicator | RNAZ | IVDA |
|---|---|---|
| Relative Strength Index (RSI) | 28.76 | 49.26 |
| Support Level | N/A | $0.24 |
| Resistance Level | $6.15 | $0.34 |
| Average True Range (ATR) | 0.36 | 0.07 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 8.33 | 13.81 |
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.